Abstract:Background and aim: Hypoxia invariably develops as solid tumors enlarge, and there are unique cellular adaptations to ensure tumor survival in these conditions.Our previous work demonstrated a key role for K-RAS in the induction of angiogenic factors VEGF and IL-8 in hypoxic conditions.We have identified adrenomedullin (ADM) as a novel target of K-RAS in hypoxia and sought to determine its functional role in CRC.Methods: We performed cDNA microarray studies using DKS-5 cells with a K-RAS (D13) mutation and DKO-3 cells in which the mutant K-RAS oncogene was knocked-out.ADM expression was verified by Q-PCR and ELISA in CRC cells by knocking-down or overexpressing mutant K-RAS.ADM expression in 56 human colorectal tumors (K-RAS mutant=14, WT=42) was evaluated by immunohistochemistry.The functional roles on cell migration, invasion, and proliferation were determined after exogenous administration of ADM peptide or siRNA knockdown of ADM In Vitro.Results: Microarrays demonstrated that ADM was significantly upregulated in mutant K-RAS (D13) cells relative to isogenic WT K-RAS cells in hypoxic conditions.qPCR and ELISA assays confirmed the induction of ADM mRNA (17 fold) and protein (4.5 fold) by the combination of K-RAS and hypoxia.The hypoxic induction of ADM was reduced 70-89% when K-RAS was knocked-down in DLD1, HCT116, and SW480 cell lines.Stable expression of mutant K-RAS in Caco2 cells induced ADM expression 2.4 fold.The induction of ADM by K-RAS and hypoxia depended upon HIF-1, as this induction was blocked by knockdown of HIF-1alpha.In addition, inhibition of PI3K but not MEK1 suppressed the induction both HIF-1 and ADM in hypoxic conditions.Administration of 200 nmol/L ADM stimulated migration (217% ± 42%, p<0.001), invasion (195% ± 4.0%, p<0.001) and proliferation (146% ± 6.0%, p<0.01) of SW480 cells.Interestingly, ADM induced VEGF levels 1.5 fold, and knockdown of ADM suppressed VEGF levels to 32% of baseline.Finally, a significant correlation was observed between ADM protein staining and the K-RAS genotype in human CRC samples, with moderate to strong staining of ADM seen in 71% of K-RAS mutant tumors vs. 40% of K-RAS WT tumors (p<0.05).Conclusion: Adrenomedullin is a novel target of K-RAS and hypoxia in colon cancer.K-RAS regulates the hypoxic induction of ADM through the PI3K and HIF-1 pathways.In addition to stimulating colon cancer cell invasion and growth, ADM can regulate angiogenesis through the induction of VEGF.Collectively, these findings highlight the importance of K-RAS and ADM in colon tumor survival in hypoxic conditions.

Adrenomedullin/<scp>FOXO3</scp> enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting <scp>FDX1</scp> expression and cuproptosis

Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis

Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway

Integrating Bulk-Rna and Single-Cell Analysis Reveals Heterogeneous Expression of Cuproptosis-Related Sorafenib-Resistant Genes in Hepatocellular Carcinoma

Adrenomedullin is a Novel K-RAS Target Gene That Regulates Cellular Invasion and Angiogenesis in Hypoxia

Circular RNA Circagap1 Promotes Sunitinib Sensitivity in Renal Cell Carcinoma Via Sponging Multiple PDGFR-targeted Mirnas

N 6 -methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma

Sphingosine Kinase 1 Overexpression Contributes to Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis

circFOXO3 Induced by KLF16 Modulates Clear Cell Renal Cell Carcinoma Growth and Natural Killer Cell Cytotoxic Activity through Sponging miR-29a-3p and miR-122-5p

Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma

Cuprous Oxide Nanoparticles Trigger ER Stress-Induced Apoptosis by Regulating Copper Trafficking and Overcoming Resistance to Sunitinib Therapy in Renal Cancer.

The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

Elucidating Mechanisms of Sunitinib Resistance in Renal Cancer: an Integrated Pathological-Molecular Analysis.

Establishment of Sunitinib-Resistant Xenograft Model of Renal Cell Carcinoma and the Identification of Drug-Resistant Hub Genes and Pathways

TRIB3 knockdown increases the sensitivity of clear cell renal cell carcinoma to sunitinib by inducing ferroptosis

Decoding sunitinib resistance in ccRCC: Metabolic-reprogramming-induced ABAT and GABAergic system shifts

LINC00160 Mediates Sunitinib Resistance Via SAA1/STAT3 Signaling Pathways and ABCB1 Transmembrane Transport in Renal Cell Carcinoma

CXCL3/TGF-β-mediated crosstalk between CAFs and tumor cells augments RCC progression and sunitinib resistance.

A Novel Cuproptosis-Related Prognostic Gene Signature in Adrenocortical Carcinoma

CXCL3/TGF- I3- Mediated Crosstalk Between CAFs and Tumor Cells Augments RCC Progression and Sunitinib Resistance